In vitro, miR‐214 disrupts mitochondrial oxidative phosphorylation in CKD by binding to specific targets, namely the mitochondrial genes mitochondrially encoded NADH dehydrogenase 6 (mt‐Nd6) and mt‐Nd4l [118]. Here, MT-ND6 is linked to chronic kidney disease.